Private equity's most dashing dealmaker faces a date in court.
An unusual source of filmic inspiration for a private equity firm's name.
Sun Capital moves in for Hostess Brands.
Paul McCartney rocks up at David Bonderman's 70th birthday party.
The firm that's invested in a provider of gloves for wheelchair rugby.
A fond farewell to Mitt Romney.
The Vulture doesn’t wish to drag his readers into the mire, so he will tread lightly upon hearing the rousing news that ANI Pharmaceuticals, backed by a group of US private equity firms including Argentum Capital Partners, has bought the makers of a female version of Viagra – via a take-private.
More tomfoolery from the website of Better Capital, home of the notorious “Private Equity A-Z”, which defines Alchemy as “a former private equity investor”.
Real Deals’ Lovecraftian cover story is about the pitfalls of failing to fall into line with basic ESG standards, and another example of this is brewing in the US.
While perusing the staff list at Axa Private Equity, I was somewhat surprised to find that Helena Bonham Carter is taking method acting to new levels by working for the firm under the name of Beatrice Beitmann.
Register for market intelligence, deal information and insight every weekday.